Trial intelligence / Profile preview

Coenzyme Q10 for oxidative stress in bipolar depression

IRCT2017022722965N7Phase 2Completed

Sponsor
Vice Chancellor for research of Hamadan University of Medical Sciences
Start
Oct 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of coenzyme q10 in bipolar disorder (BD), sponsored by Vice Chancellor for research of Hamadan University of Medical Sciences. Started Oct 2016; status: completed.

02

Drugs

coenzyme q10
03

Conditions

bipolar disorder (BD)

Beyond the preview

Go deeper on IRCT2017022722965N7.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2017022722965N7.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call